Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		139,159,534
Beginning balance at Dec. 31, 2022	$ 1,116,780	$ 14	$ 2,068,225	$ (2,316)	$ (949,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		272,032
Exercise of stock options	3,651		3,651
Stock-based compensation	47,060		47,060
Issuance of common stock upon settlement of restricted stock units (in shares)		940,122
Other comprehensive income (loss)	308			308
Net loss	(63,447)				(63,447)
Ending balance (in shares) at Mar. 31, 2023		140,371,688
Ending balance at Mar. 31, 2023	1,104,352	$ 14	2,118,936	(2,008)	(1,012,590)
Beginning balance (in shares) at Dec. 31, 2022		139,159,534
Beginning balance at Dec. 31, 2022	1,116,780	$ 14	2,068,225	(2,316)	(949,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(160,175)
Ending balance (in shares) at Sep. 30, 2023		143,452,776
Ending balance at Sep. 30, 2023	1,123,751	$ 14	2,235,480	(2,425)	(1,109,318)
Beginning balance (in shares) at Mar. 31, 2023		140,371,688
Beginning balance at Mar. 31, 2023	1,104,352	$ 14	2,118,936	(2,008)	(1,012,590)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		549,328
Exercise of stock options	7,304		7,304
Stock-based compensation	44,647		44,647
Issuance of common stock upon settlement of restricted stock units (in shares)		963,723
Issuance of common stock for employee stock purchase plan (in shares)		316,042
Issuance of common stock for employee stock purchase plan	13,006		13,006
Other comprehensive income (loss)	7			7
Net loss	(52,881)				(52,881)
Ending balance (in shares) at Jun. 30, 2023		142,200,781
Ending balance at Jun. 30, 2023	1,116,435	$ 14	2,183,893	(2,001)	(1,065,471)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		311,427
Exercise of stock options	4,071		4,071
Stock-based compensation	47,516		47,516
Issuance of common stock upon settlement of restricted stock units (in shares)		940,568
Other comprehensive income (loss)	(424)			(424)
Net loss	(43,847)				(43,847)
Ending balance (in shares) at Sep. 30, 2023		143,452,776
Ending balance at Sep. 30, 2023	1,123,751	$ 14	2,235,480	(2,425)	(1,109,318)
Beginning balance (in shares) at Dec. 31, 2023		144,806,464
Beginning balance at Dec. 31, 2023	1,155,610	$ 15	2,295,807	(1,375)	(1,138,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		471,310
Exercise of stock options	7,140		7,140
Stock-based compensation	42,590		42,590
Issuance of common stock upon settlement of restricted stock units (in shares)		994,029
Other comprehensive income (loss)	(693)			(693)
Net loss	(10,966)				(10,966)
Ending balance (in shares) at Mar. 31, 2024		146,271,803
Ending balance at Mar. 31, 2024	1,193,681	$ 15	2,345,537	(2,068)	(1,149,803)
Beginning balance (in shares) at Dec. 31, 2023		144,806,464
Beginning balance at Dec. 31, 2023	$ 1,155,610	$ 15	2,295,807	(1,375)	(1,138,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	962,063
Net loss	$ (43,665)
Ending balance (in shares) at Sep. 30, 2024		148,663,793
Ending balance at Sep. 30, 2024	1,285,649	$ 15	2,468,450	(314)	(1,182,502)
Beginning balance (in shares) at Mar. 31, 2024		146,271,803
Beginning balance at Mar. 31, 2024	1,193,681	$ 15	2,345,537	(2,068)	(1,149,803)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		294,901
Exercise of stock options	2,779		2,779
Stock-based compensation	52,721		52,721
Issuance of common stock upon settlement of restricted stock units (in shares)		835,497
Issuance of common stock for employee stock purchase plan (in shares)		276,349
Issuance of common stock for employee stock purchase plan	13,187		13,187
Other comprehensive income (loss)	(259)			(259)
Net loss	(6,311)				(6,311)
Ending balance (in shares) at Jun. 30, 2024		147,678,550
Ending balance at Jun. 30, 2024	1,255,798	$ 15	2,414,224	(2,327)	(1,156,114)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		195,852
Exercise of stock options	2,452		2,452
Stock-based compensation	51,774		51,774
Issuance of common stock upon settlement of restricted stock units (in shares)		789,391
Other comprehensive income (loss)	2,013			2,013
Net loss	(26,388)				(26,388)
Ending balance (in shares) at Sep. 30, 2024		148,663,793
Ending balance at Sep. 30, 2024	$ 1,285,649	$ 15	$ 2,468,450	$ (314)	$ (1,182,502)